BeStock  
Stocks › Medical Devices › PACB

Pacific Biosciences of California PACB

US equityMarket cap rank #3575Medical Devices
$1.63 −$0.13 (-7.39%)
Market closed · Nov 21, 9:10 am ET · Last extended-hours $1.63 +0.28%
Open$1.69
Prev close$1.76
Day range$1.61 – $1.73
Volume13.69M
Market cap$510.07M
P/E (TTM)–
Dividend yield–

Analyst view

ConsensusHold
Analysts5
Average target$2.64+62.0% vs. price
  • Buy 40%
  • Hold 40%
  • Sell 20%
Low $2.00Now $1.63Avg $2.64High $3.00

Recent rating changes

The last 20 actions on file set price targets from $1.00 to $3.00, averaging $2.35.

DateFirmRatingTarget
9 Nov 2026 UBS HOLD $2.70
5 Nov 2026 CCORF BUY $3.00
5 Nov 2026 Piper Sandler HOLD $3.00
5 Nov 2026 Barclays SELL $2.00
23 Oct 2026 Stephens BUY $2.50
7 Oct 2026 Barclays SELL $1.25
11 Sep 2026 CCORF BUY –
17 Aug 2026 CCORF BUY $3.00
6 Aug 2026 TD Cowen BUY $3.00
6 Aug 2026 CCORF BUY $3.00
6 Aug 2026 Piper Sandler HOLD $2.00
5 Aug 2026 Barclays SELL $1.25
8 May 2026 TD Cowen BUY $3.00
8 May 2026 CCORF BUY $3.00
8 May 2026 Piper Sandler HOLD $2.00
8 May 2026 Barclays SELL $1.50
14 Apr 2026 Barclays SELL $1.00
19 Mar 2026 CCORF BUY $3.00
6 Mar 2026 Barclays SELL $1.50
13 Feb 2026 CCORF BUY $3.00

Discussion

No comments yet — be the first to weigh in on PACB.

Sign in to join the discussion.

Scroll to Top